PREX2 and cancer: Moreover, cancer-associated mutations in PREX2 disrupt these mutual inhibition processes: mutated PREX2 can still inhibit PTEN, but PTEN cannot inhibit mutated PREX2 (Mense et al., 2015; Figure 1B).